In general, infectious diseases are more frequent and/or serious in patients with diabetes mellitus, which potentially increases their morbimortality. The greater frequency of infections in diabetic patients is caused by the hyperglycaemic environment that favours immune dysfunction (e.g., damage to the neutrophil function, depression of the antioxidant system, and humoral immunity),
micro-and macro-angiopathies, neuropathy, decrease in the antibacterial activity of urine, gastrointestinal and urinary dysmotility, and greater number of medical interventions in these patients. The infections affect all organs and systems.
Infections in patients with diabetes mellitus: A review of pathogenesis, Indian Journal of Endocrinology and Metabolism, 2012, March 16 (Suppl) S27-S36., uliana Casqueiro, Janine Casqueiro, and Cresio Alves
Cognisharp (L Carnosine) – Diabetes control
Two-hour glucose and insulin were both lower after carnosine supplementation compared to placebo in individuals with impaired glucose tolerance (P < 0.05).
Effects of Carnosine Supplementation on Glucose Metabolism: Pilot Clinical Trial, Barbora de Courten et al. Obesity (Silver Spring). 2016 May;24(5):1027-34,
Carnosine supplementation was found to decrease HbA1C levels in the intervention group compared to the control group. In addition, carnosine could induce lipoprotein lipase activity40 and serve as a free radical scavenger to reduce lipid parameters
Complementary Therapies in Medicine, 48(2020), Weixia Peng et. al.